Literature DB >> 17714489

Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus.

Claire Daurel1, Anne-Laure Prunier, Françoise Chau, Louis Garry, Roland Leclercq, Bruno Fantin.   

Abstract

This study was designed to investigate the role of hypermutability of Staphylococcus aureus on bacterial fitness and antibiotic resistance in a model of chronic bone infection. An isogenic pair of strains, S. aureus RN4220 and its mutator counterpart inactivated in the mutL gene were used in a rat model of osteomyelitis of the tibia. The effect of the mutator phenotype in the emergence of antibiotic resistance was assessed in rats infected by each strain separately and treated with rifampicin for 5 days. No difference between the two strains was found in bacterial growth in vitro and in bacterial survival in the animal model, indicating no fitness defect in the mutator strain. In competition studies performed in rats coinfected with the two strains at a same ratio and sacrificed at different times from day 3 to day 42 postinoculation, the mutator strain was clearly disadvantaged because it was found in all rats and at all study times at lower counts (P<0.05 from day 14 to day 42). Two of the 16 rats infected by the mutator strain and none of the 14 rats infected by the wild-type strain had acquired rifampicin-resistant mutants (P=0.4). Data suggest that the S. aureus mutator phenotype was associated with a decreased bacterial fitness in vivo and did not confer significant advantage in the acquisition of antibiotic resistance in a model of chronic bone infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714489     DOI: 10.1111/j.1574-695X.2007.00310.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  6 in total

1.  Recombination between ccrC genes in a type V (5C2&5) staphylococcal cassette chromosome mec (SCCmec) of Staphylococcus aureus ST398 leads to conversion from methicillin resistance to methicillin susceptibility in vivo.

Authors:  Monika A Chlebowicz; Kristelle Nganou; Svitlana Kozytska; Jan P Arends; Susanne Engelmann; Hajo Grundmann; Knut Ohlsen; Jan Maarten van Dijl; Girbe Buist
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

2.  Evolution in fast forward: a potential role for mutators in accelerating Staphylococcus aureus pathoadaptation.

Authors:  Gregory S Canfield; Johanna M Schwingel; Matthew H Foley; Kelly L Vore; Kanitsak Boonanantanasarn; Ann L Gill; Mark D Sutton; Steven R Gill
Journal:  J Bacteriol       Date:  2012-11-30       Impact factor: 3.490

3.  Rapid emergence of resistance to linezolid and mutator phenotypes in Staphylococcus aureus isolates from an adult cystic fibrosis patient.

Authors:  Asmaa Tazi; Jeanne Chapron; Gerald Touak; Magalie Longo; Dominique Hubert; Gislène Collobert; Daniel Dusser; Claire Poyart; Philippe C Morand
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

4.  Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with and without a hypermutator phenotype.

Authors:  Boubakar B Ba; Corinne Arpin; Branly Bikie Bi Nso; Véronique Dubois; Marie-Claude Saux; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2010-01-25       Impact factor: 5.191

5.  Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health.

Authors:  Gabriel G Perron; R Fredrik Inglis; Pleuni S Pennings; Sarah Cobey
Journal:  Evol Appl       Date:  2015-03-23       Impact factor: 5.183

Review 6.  The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology.

Authors:  Federica Natali; Giulia Rancati
Journal:  Front Genet       Date:  2019-08-06       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.